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The cystic fibrosis transmembrane conductance regulator (CFTR) undergoes rapid turnover at the plasma membrane in various cell types. The
ubiquitously expressed N-WASP promotes actin polymerization and regulates endocytic trafficking of other proteins in response to signaling
molecules such as Rho-GTPases. In the present study we investigated the effects of wiskostatin, an N-WASP inhibitor, on the surface expression
and activity of CFTR. We demonstrate, using surface biotinylation methods, that the steady-state surface CFTR pool in stably transfected BHK
cells was dramatically decreased following wiskostatin treatment with a corresponding increase in the amount of intracellular CFTR. Similar
effects were observed for latrunculin B, a specific actin-disrupting reagent. Both reagents strongly inhibited macroscopic CFTR-mediated Cl−
currents in two cell types including HT29-Cl19A colonic epithelial cells. As previously reported, CFTR internalization from the cell surface was
strongly inhibited by a cyclic-AMP cocktail. This effect of cyclic-AMP was only partially blunted in the presence of wiskostatin, which raises the
possibility that these two factors modulate different steps in CFTR traffic. In kinetic studies wiskostatin appeared to accelerate the initial rate of
CFTR endocytosis as well as inhibit its recycling back to the cell surface over longer time periods. Our studies implicate a role for N-WASP-
mediated actin polymerization in regulating CFTR surface expression and channel activity.
© 2006 Elsevier B.V. All rights reserved.Keywords: CFTR; Actin; N-WASP; Wiskostatin; Latrunculin B; Endocytosis; Cyclic-AMP1. Introduction
The cystic fibrosis transmembrane conductance regulator
(CFTR) is a chloride-selective ion channel found in epithelial
cells lining the gastrointestinal tract, airways and reproductive
organs. Mature, glycosylated CFTR is delivered from post-golgi
compartments to the apical plasma membrane where it regulates
the vectorial transport of ions and water across the cell
membrane. Interestingly, the wild type protein has a relatively
long half-life (16–24 h in most cell types), although it exhibits
rapid turnover (withinminutes) at the surfaces of many cell types
[1,2]. Biochemical, biophysical and functional studies of T84
colonic epithelial cells and stably transfected Chinese hamster
ovary cells provided evidence that CFTR is rapidly internalized⁎ Corresponding author. Tel.: +1 205 934 3122; fax: +1 205 934 5787.
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doi:10.1016/j.bbamcr.2006.09.031from the plasma membrane by clathrin-coated vesicles [2,3].
The C-terminal tail of CFTR contains two structural features that
are important for its endocytosis; (i) a dileucine (1430LL) motif
and (ii) a tyrosine-based motif (1424YDSI1427). The latter motif
interacts with the clathrin adapter protein complex (AP-2),
which facilitates entry of the ion channel into coated pits [4,5].
Internalized CFTR channels appear to be capable of rapidly
recycling back to the plasma membrane, presumably via re-
cycling endosomes [6], which could possibly modulate CFTR
expression at the cell surface [7]. However, the mechanism and
itinerary of CFTR recycling is not fully understood.
Several studies indicate that the components of the clathrin-
mediated endocytic machinery directly or indirectly interact
with the actin cytoskeleton, which forms a scaffolding structure
beneath the plasma membrane [8,9]. Disruption of the actin
filament network has been demonstrated to compromise the
endocytic trafficking of some proteins such as the transferrin
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others have reported no effect on clathrin-mediated endocytosis
[12,13]. Recently, Swiatecka-Urban et al., have reported that
CFTR interacts with a complex of actin-binding proteins
including myosin VI that facilitate CFTR endocytosis and that
may regulate CFTR expression at the cell surface [14]. In
addition it was reported that CFTR-mediated Cl− currents were
insensitive to stimulation by cyclic-AMP in whole cells or to
direct addition of PKA to excised patches when the actin
cytoskeleton was first completely disrupted [15,16]. The authors
proposed that a direct interaction between the actin filaments
and CFTR was a prerequisite for stimulating channel activity.
In the present study we investigated the effects of two actin-
disrupting reagents, namely, wiskostatin and latrunculin B, on
regulating the surface expression and activity of CFTR.
Wiskostatin is a cell-permeant compound that stabilizes
NQWASP in its native, autoinhibited conformation thereby
preventing actin polymerization [17–19]. The WASP family
proteins are emerging as central regulators of actin assembly
vis-à-vis their interactions with Rho family GTPases, phospha-
tidylinositol 4,5 bisphosphate (PIP2) and Arp2/3 complexes.
Moreover, several studies indicate that N-WASP regulates
endocytosis and exocytosis, presumably via its role in
modulating actin assembly [20–22]. Latrunculin B, which
causes actin filament disassembly by sequestering actin
monomers, was reported to block the recycling of G-protein
coupled receptors internalized in response to β-agonists in
human carcinoma cells [23].
We show that wiskostatin substantially reduced the steady-
state surface pool of CFTR in biochemical studies in which cell
surface CFTR was labeled using a cleavable biotinylating
reagent (NHS-SS-biotin). Concomitantly, there was a dramatic
increase in the amount of CFTR that accumulated within the
cells following wiskostatin treatment although the total CFTR
content in the lysates was not appreciably altered. Similar
results were obtained using latrunculin B. Both wiskostatin and
latrunculin B also dramatically decreased CFTR-mediated
currents in two cell types including HT29-Cl19A colonic
epithelial cells. In detailed kinetic studies we observed that
wiskostatin had complex effects on both the time course of
CFTR endocytosis and recycling implying that it may affect
both processes. Our results indicate that the filamentous actin
and/or N-WASP-dependent actin assembly play a modulatory
role in the endocytic trafficking of CFTR.2. Materials and methods
2.1. Cell culture
BHK cells that were stably transfected with full-length wild-type human
CFTR were a gift from J.W. Hanrahan and cultured as described [24]. HT29-
CL19A human colonic epithelial cells expressing native CFTR were propagated
as described previously [25].
2.2. Cell surface biotinylation
Cell surface proteins were biotinylated with sulfosuccinimidyl-2-(biotina-
mido)ethyl-1,3-dithiopropionate (sulfo-NHS-SS-Biotin) following previouslypublished protocols [2] with minor modifications. Briefly, BHK-CFTR cells
grown in 100-mm dishes were incubated with indicated concentrations of
wiskostatin (Calbiochem) or DMSO (vehicle) for 2 h at 37 °C. Further steps
were performed at 0 °C. Cells were rinsed with ice-cold PBS (137 mM NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.4) containing 0.1 mM
CaCl2 and 1 mMMgCl2 (PBS-CM) and incubated with 1 mg/ml EZ-Link Sulfo-
NHS-SS-biotin (Pierce) in PBS (pH adjusted to 8.0) for 30 min. Cell monolayers
were rinsed with cold PBS-CM and unreacted biotin molecules were quenched
with PBS containing 1% BSA for 10 min before cell lysis and streptavidin–
agarose capture.
2.3. CFTR internalization assay
To assay the internalization of cell surface CFTR, cell surface proteins were
biotinylated as above, after which the cells were warmed to 37 °C for varying
time periods in the presence of wiskostatin, latrunculin B (Calbiochem) or
DMSO (vehicle). In some experiments a cyclic-AMP cocktail (100 μM cpt-
cAMP, 20 μM forskolin, 1 mM IBMX) was added to the cells at this stage. At
the indicated time points, cells were rapidly cooled by rinsing with cold PBS-
CM and biotin molecules exposed at the cell surface were cleaved with a
membrane impermeant stripping solution (100 mM MESNA (mercaptoethane-
sulfonic acid; Sigma), 50 mM Tris, 100 mM NaCl, 1 mM EDTA, 0.2% (w/v)
BSA, adjusted to pH 8.0). Cells were treated with 3 changes of stripping solution
for 15 min each on ice to ensure complete removal of surface-exposed biotin.
Stripped cells were rinsed with cold PBS-CM and processed for lysis.
2.4. Cell lysis, streptavidin–agarose capture and immunoblotting
Cells were lysed with 1 ml PBS containing 1% (v/v) Triton X-100 and
protease inhibitor cocktail (Roche). Lysates were centrifuged (10,000×g) to
remove cell debris and protein concentrations of clarified lysates were estimated
by standard micro-BCA protein assay (Pierce). Equivalent amounts of cell
lysates (2 mg) were rotated with 50 μl of packed streptavidin–agarose
(Novagen) overnight at 4 °C. The streptavidin–agarose beads were washed
extensively with lysis buffer and bound proteins were eluted with Laemmli
buffer and separated by SDS-PAGE on 4–15% gradient gels (Bio-Rad) followed
by immunoblotting on polyvinylidene difluoride membranes (Millipore). CFTR
protein was detected using monoclonal antibodies against the C-terminal tail
(clones 24-1, R&D Research and GA-1, Santa Cruz Biotech.) and protein bands
were visualized by enhanced chemiluminescence (Pierce). Signals were
quantified by densitometric scanning followed by analysis with Scion Image
(release beta 4.0.2) (Scion Corp.).
2.5. Electrophysiology
BHK-CFTR cells were grown on plastic coverslips for excised inside-out
patch clamp recordings. Patch pipettes were pulled to tip resistances of
3–4 mOhm. CFTR channels were activated following patch excision by PKA
catalytic subunit (110 U/ml) and 1.5 mM Mg2+–ATP. Macroscopic currents
were recorded in symmetrical solutions containing (in mM): 140 N-methyl-D-
glucamine-Cl, 3 MgCl2, 1 EGTA and 10 TES (pH 7.3). Experiments were
performed at 21–23 °C. Currents were evoked using a voltage ramp protocol
from +80 to −80 mV with a 10 s time period. Data acquisition was performed
using pCLAMP9 software (Axon Instruments).
Whole-cell recordings were obtained from HT29-Cl19A cells using methods
as previously described [26] and solutions in which Cl− was the only permeant
species as previously described for epithelial cells [25]. All experiments were
conducted at room temperature (22–24 °C) using an EPC-9 patch clamp
amplifier (HEKA Electronik GmbH, Germany) and using the Pulse+PulseFit V
8.65 acquisition program (HEKA Electronik GmbH, Germany). Patch-clamp
pipettes were pulled to resistances of 6–8 MOhms. using quartz glass and a
Sutter model P-2000 puller (Sutter Instrument Co., CA). The pipette solution
contained (in mM): 140 N-methyl D-glucamine; 40 HCl; 100 L-glutamic acid;
0.2 CaCl2; 2 MgCl2; 1 EGTA; 10 HEPES; and 2 ATP–Mg, pH 7.2. The bath
solution contained (in mM): 140 N-methyl D-glucamine; 140 HCl; 2 CaCl2;
1 MgCl2; and 10 HEPES, pH 7.4. The Cl
− equilibrium potential in these
experiments was −31 mV. CFTR channels were maximally stimulated by the
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forskolin, 1 mM IBMX ) to the pipette solution with voltage steps ranging from
−110 to +110 mV in increments of 10 mV from a holding potential of −40 mV.
Data were acquired using a Pentium 4 PC and analyzed off-line using the
integrated graphics package, IGOR Pro (WaveMetrics, OR).
2.6. Data analysis and statistics
Each experiment was repeated at least 3 times. The data are expressed as the
means±S.E. Statistical analysis was performed using student's unpaired t test
(two-tailed) to compare the means, and significance was determined at p<0.05.3. Results
3.1. Wiskostatin decreases steady-state levels of surface CFTR
BHK-CFTR cells were incubated at 0 °C with NHS-SS-
biotin in order to label CFTR at the cell surface. This reagent
covalently binds to extracellular residues (most likely lysines)
on surface proteins (see Materials and methods) and has been
used extensively to label surface CFTR [2,27]. In the initial
experiments we determined the dose of wiskostatin that
produced a maximal effect on CFTR expression at the cell
surface. Previous in vitro studies have reported that wiskostatin
binds to WASP fragments with an apparent Kd ∼100 μM [17].
We observed that the actin cytoskeleton was disrupted in
>90% of cells treated with this dose of wiskostatin for 2 h by
staining with phalloidin-alexa-fluor-488 (not shown). There-
fore, BHK-CFTR cells were treated with 0–100 μM wiskos-
tatin for 2 h prior to biotinylation and subsequent cell lysis.
Incubating cells for longer time periods or with higher
concentrations resulted in loss of cell adherence that interfered
with subsequent washing and processing steps. Biotinylated
proteins were captured with streptavidin–agarose beadsFig. 1. Wiskostatin decreases steady-state surface CFTR expression in a dose-depend
with NHS-SS-biotin. (A) Surface-biotinylated CFTR captured with streptavidin–aga
vehicle or indicated doses of wiskostatin for 2 h. Band C represents mature, fully
experiment in which additional lanes not relevant to this experiment were remo
densitometry and normalized to the CFTR signals in vehicle-treated cells. The barsfollowing cell lysis and CFTR was detected using monoclonal
antibodies to its C-terminal tail. Total CFTR was detected by
directly immunoblotting the cell lysates. As shown in the panel
representing the streptavidin-bound fraction of CFTR (Fig. 1A,
upper panel), there was a dose-dependent decrease in the
surface CFTR signal in the presence of wiskostatin. We
determined by densitometry (Fig. 1B) that about 80% of the
CFTR signal was lost from the cell surface at the highest dose
of wiskostatin (100 μM) as compared to vehicle control. There
was, however, no appreciable change in the total CFTR
content in the lysates at all doses of wiskostatin (Fig. 1A,
lower panel). From these results it is clear that wiskostatin
causes a substantial decrease in CFTR levels at the cell surface
but does not alter the total CFTR content of cells (at least for
the time and doses used in this study).
3.2. Wiskostatin and latrunculin B cause CFTR to accumulate
within cells
Since the preceding results indicated that CFTR was
removed from the cell surface following wiskostatin treat-
ment, we next examined the fate of the internalized protein in
these cells (Fig. 2). Since N-WASP is known to regulate actin
assembly in cells, we also tested the effects of a known actin-
disrupting reagent, namely, latrunculin B on the fate of
CFTR. In these experiments BHK-CFTR cells were first
incubated with NHS-SS-biotin on ice (to inhibit endocytosis)
and then incubated in the presence or absence of wiskostatin
or latrunculin B for 2 h at 37 °C. During this warming period
the cell surface proteins are continuously endocytosed and
recycled and reach a new steady-state distribution between the
cell surface and intracellular compartments (refer to detailed
time-course experiments in Fig. 6). Next, the labeled proteinsent manner. Top panel, schematic representation of labeling cell-surface proteins
rose (upper) or total CFTR protein (lower) in lysates of BHK cells treated with
glycosylated CFTR. The blots in the upper panel represent data from a single
ved. (B) CFTR signals at indicated doses of wiskostatin were quantified by
represent means±S.E. calculated from 3 separate experiments.
Fig. 2. Wiskostatin and latrunculin B increase the fraction of surface-biotinylated CFTR that accumulates within the cells at steady-state. Top panel is a schematic
representation of the CFTR internalization assay. t0 represents surface CFTR molecules labeled before wiskostatin/latrunculin B treatment (2 h each). (A) Biotinylated
CFTR (upper) or total CFTR protein (lower) in lysates of BHK cells treated with vehicle or indicated doses of latrunculin B or wiskostatin. (B) CFTR signals at
indicated doses of wiskostatin or latrunculin B were quantified by densitometry and normalized to the CFTR signal at t0. Note that >95% of signal is lost in samples
stripped by MESNA at t0. The bars represent means±S.E. of 3 separate experiments. The asterisks indicate p<0.05 relative to vehicle control.
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membrane-impermeant reducing reagent, MESNA [2]. The
stripping efficiency was determined to be >95% for control
cells that were not warmed to 37 °C (see Fig. 2B).
Biotinylated proteins were captured with streptavidin–agarose
and immunoblotted with CFTR antibodies to detect the
fraction of initially labeled CFTR that was present inside the
cells at steady-state. We observed a dose-dependent increase
in the amount of labeled CFTR that accumulated in the cells
at steady-state in the presence of wiskostatin; >80% of the
surface-labeled CFTR accumulated inside the cells at 100 μM
wiskostatin as compared to ∼30% in control (vehicle-treated)
cells over a period of 2 h. Similarly, in the presence of 10 μM
latrunculin B, 60–70% of surface-biotinylated CFTR accu-
mulated in the cells at steady-state (Fig. 2A, B). The IC50 for
latrunculin B is typically in the submicromolar range, and at
doses >10 μM was toxic to the cells. Again there was no
change in the CFTR content in the lysates at all doses of
wiskostatin or latrunculin B. Together with the results shown
in Fig. 1, these data indicate that wiskostatin and latrunculin
caused CFTR to dramatically relocate from the cell surface to
intracellular compartments.
We also observed that latrunculin B showed a tendency to
reduce steady-state CFTR expression at the cell surface using
the assay of Fig. 1, but the results obtained with this compound
were not as reproducible as with wiskostatin (not shown). This
disparity could be due to the fact that these reagents have
different molecular targets and/or that wiskostatin has a more
consistent effect on actin organization.3.3. Wiskostatin and latrunculin B decrease CFTR-mediated
currents in BHK membrane patches and in HT29 colonic
epithelial cells
The preceding results indicate that macroscopic CFTR
currents should be reduced by wiskostatin if it indeed causes
CFTR to redistribute from the cell surface to the cell interior. In
order to test this prediction we performed two complementary
functional assays in different cell types, (i) macroscopic excised
patch clamp experiments in BHK-CFTR cells expressing high
levels of recombinant human CFTR and (ii) whole-cell patch
clamp studies in HT29-Cl19A human colonic epithelial cells
expressing low levels of native CFTR. The BHK-CFTR cells
were pre-treated with wiskostatin following which inside-out
membrane patches were excised using large tip pipettes. CFTR-
mediated currents were activated by adding normally saturating
concentrations of PKA and Mg-ATP to the bath. In control
patches excised from untreated cells, the CFTR-mediated
currents were of typically high magnitude (>400 pA; Fig. 3A)
due to the presence of several hundred CFTR channels per patch
[28]. The fact that the elicited currents were (i) Mg-ATP-
dependent (not shown) and (ii) inhibited by addition of the
voltage-dependent pore-blocker glibenclamide (see Fig. 3A)
confirmed that the currents were CFTR-mediated. By compar-
ison, the PKA-activated and Mg-ATP-dependent currents were
consistently much smaller for membrane patches excised from
wiskostatin-treated cells (Fig. 3B, C) as also for membrane
patches excised from cells pre-treated with latrunculin B
(Fig. 3C). The low magnitude of the CFTR-mediated currents
Fig. 4. Whole-cell Cl− currents are decreased in HT29-Cl19A cells pre-treated
with wiskostatin or latrunculin B. (A) Representative cyclic-AMP-activated Cl−
currents recorded in control HT29-Cl19A cells and cells pretreated with either
latrunculin B (4 μM) or wiskostatin (10 μM) for 2 h. (B) Average current–
voltage relationships for the cyclic-AMP-dependent currents in control cells
(n=5) and cells treated with latrunculin B (n=5) or wiskostatin (n=4).
Fig. 3. CFTR-mediated chloride currents across excised membrane patches are reduced by pre-treating BHK-CFTR cells with wiskostatin or latrunculin B. (A, B)
Representative macroscopic currents recordings for inside-out membrane patches excised from a control BHK-CFTR cell (A) or from a cell pre-treated with 5 μM
wiskostatin for 2 h (B). Inhibitory PKA peptide (PKI; 1.4 μg/ml) was added at the first arrow followed by glibenclamide (250 μM), a voltage-dependent pore blocker.
Currents were elicited using a voltage ramp protocol (see Materials and methods). (C) Mean glibenclamide-sensitive currents (at −80 mV) for membrane patches
excised from control cells and from cells pre-treated for 2 h with wiskostatin (5 μM) or latrunculin B (1 μM). Data are means±S.D. calculated from 4 to 7 experiments.
Asterisk indicates p<0.05 relative to control. (p=0.09, for latrunculin B-treated cells).
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drastically reduced and/or that the existing channels had very
low activity. Because the biochemical results indicated that
wiskostatin substantially decreases the number of CFTR
molecules at the cell surface, one explanation is that the
reduced currents are due to a decrease in the channel density at
the plasma membrane. However, it is worth noting that CFTR-
mediated currents were inhibited by up to 80% (Fig. 3C) by a
dose of wiskostatin (5 μM) that did not produce an equivalent
decrease in surface-labeled CFTR (see Fig. 1) (membrane
patches could not be reliably obtained at higher doses of
wiskostatin). This disparity may be due to the different
conditions under which these two assays were performed. In
order to test the possibility that wiskostatin could possibly affect
the regulatory properties of CFTR as well, wiskostatin (5 μM)
was added directly to the cytoplasmic side of excised membrane
patches (results not shown). We did not observe an acute
reduction of CFTR-mediated currents under these circum-
stances, indicating that wiskostatin does not directly affect the
gating properties of CFTR channels (see Discussion).
In a complementary set of experiments, CFTR-mediated
currents were recorded in HT29-Cl19A epithelial cells under
control (untreated) or wiskostatin-treated conditions by whole-
cell patch clamp analysis (Fig. 4). These cells express native
CFTR and probably represent a more physiologically relevant
system for recording CFTR activity. However, these cells
express very modest levels of CFTR which makes it difficult to
conduct biochemical studies such as surface biotinylation.CFTR-mediated Cl− currents were activated by addition of a
cyclic-AMP-cocktail. These currents were validated to be
CFTR-mediated on the basis of their dependence on cyclic-
AMP activation and block by 1 mM glibenclamide or DPC (not
Fig. 6. The effects of wiskostatin on the kinetics of CFTR internalization. (A)
Biotinylated CFTR in lysates of BHK cells treated with vehicle or wiskostatin
(100 μM) for 2 h at 37 °C followed by biotinylation at 0°C. Cells were rewarmed
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reduced for wiskostatin-treated cells (Fig 4A, B). Likewise,
treatment with latrunculin B also inhibited CFTR-mediated
currents in the HT29-Cl19A cells (Fig. 4A, B). The results of
the biochemical (surface biotinylation assays) and functional
studies indicate that wiskostatin and latrunculin B have striking
effects on both the surface expression and macroscopic
functional activity of CFTR channels.
3.4. Cyclic-AMP inhibits CFTR internalization in the presence
or absence of wiskostatin
Cyclic-AMP has been reported to inhibit CFTR endocytosis,
presumably, because the active channel is not efficiently
internalized or that protein phosphorylation alters the recycling
of CFTR [1,2]. In this context we examined the effects of
wiskostatin on CFTR accumulation in cells in the presence of a
cyclic-AMP cocktail (Fig. 5). BHK-CFTR cells were first
biotinylated at 4 °C and then exposed to 100 μM wiskostatin in
the presence or absence of a cyclic-AMP cocktail for 2 h at 37
°C. Following this, the cells were stripped of surface biotin and
the fraction of labeled CFTR that accumulated inside the cells atFig. 5. cyclic-AMP inhibits net CFTR internalization from the cell-surface, but
to a lesser extent in the presence of wiskostatin. Refer to Fig. 2 for schematic.
(A) Biotinylated CFTR (upper) or total CFTR protein (lower) in lysates of BHK
cells harvested at t0 or following treatment with wiskostatin (100 μM) and/or a
cyclic-AMP cocktail for 2 h (see Materials and methods). Duplicate samples for
each condition are shown. (B) CFTR signals in the presence of wiskostatin and/
or cyclic-AMP were quantified by densitometry and normalized to the CFTR
signal at t0. The bars represent means±S.E. of 4 experiments.
to 37 °C for indicated times and the labeled CFTR remaining at the cell surface
was stripped by MESNA. Note that the surface CFTR signal was much less for
the wiskostatin-treated cells as compared to vehicle control (see also Fig. 1). (B)
CFTR signals in control or wiskostatin-treated cells were normalized to the
respective surface CFTR signals and plotted as a function of time. The data
points represent means±S.E. of 2–7 experiments.steady-state was assessed by streptavidin capture and immuno-
blotting. As previously reported, a smaller fraction of labeled
CFTR accumulated inside the cells in the presence of cyclic-
AMP as compared to control untreated cells (Fig. 5A). Cyclic-
AMP also reduced CFTR internalization in the presence of
wiskostatin, although a greater fraction of CFTR was
internalized than with cyclic-AMP alone (Fig. 5A, B). These
data indicate that cyclic-AMP inhibits CFTR internalization
even in the presence of wiskostatin, which implies that these
two factors may regulate different steps in CFTR traffic.
3.5. Wiskostatin has complex effects on the kinetics of CFTR
internalization and recycling
From the preceding results it is apparent that wiskostatin has
pronounced effects on CFTR expression at the cell surface.
CFTR channel density at the plasma membrane reflects a
balance between the rates of CFTR endocytosis and recycling
back to the cell surface. Detailed time course experiments were
performed to determine if wiskostatin primarily affected the rate
of CFTR endocytosis. BHK-CFTR cells were treated with
100 μM wiskostatin for 2 h following which cells were surface-
biotinylated at 0 °C and then warmed to 37 °C for varying times
(0–30 min). At each time point the surface biotin was stripped
with MESNA and the biotinylated CFTR inside the cells was
detected by streptavidin-capture and immunoblotting as
described (Fig. 6A). In the control cells (no wiskostatin) there
was a quasi-linear increase in the fraction of CFTR that
accumulated in the cells between 0 and 2 min. At longer times
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because the internalized CFTR is rapidly and efficiently recycled
back to the cell surface (Fig. 6B). Two differences were observed
for cells treated with wiskostatin: (i) a larger fraction of surface-
labeled CFTR was internalized in the first 2 min and (ii) the
biotinylated CFTR continued to accumulate in the cells over a
longer period and reached steady state more gradually as
compared to control (Fig. 6B). These data indicate that
wiskostatin may have multiple effects on CFTR endocytosis/
recycling: (i) an increase in the initial rate of CFTR internaliza-
tion (caused either by an increase in the fraction of labeled CFTR
molecules that can be internalized, or an increase in the intrinsic
rate of endocytosis) and (ii) a reduction in the rate of recycling of
internalized CFTRmolecules back to the cell surface (evidenced
as a slower time-course to reach steady-state).
4. Discussion
CFTR is present largely at the plasma membranes of
epithelial cells where it regulates bidirectional transport of
ions and water. The carboxy-terminal tail of CFTR contains
signals that facilitate its entry into clathrin-coated pits [5] and it
is well documented that the channel is constitutively inter-
nalized in various cell types [1,2]. The main goal of this work
was to determine if CFTR levels at the cell surface are
modulated by actin polymerization and/or N-WASP-mediated
actin assembly. We investigated the steady-state distribution of
CFTR between the plasma membrane and intracellular
compartments in response to latrunculin B, an actin depolymer-
izing agent and wiskostatin, a cell-permeable allosteric inhibitor
of N-WASP that effectively blocks actin assembly. The WASP
family proteins together with the Arp2/3 complex are key
modulators of actin assembly in various cell types. The WASP
family proteins are direct effectors for upstream signaling
molecules, namely, Rho-GTPases and PIP2, which regulate
many aspects of cell function including vesicle trafficking.
Further, the Rho-GTPases are preferred targets for toxins
secreted by opportunistic pathogens, including Pseudomonas
aeruginosa, that cause life-threatening infections in cystic
fibrosis patients. Through modulation of Rho-GTPases activity
the pathogens mediate changes in the actin cytoskeleton which
may facilitate their entry in cells [29]. In this context it was
recently reported that a cell-free filtrate of P. aeruginosa
reduced CFTR-mediated transepithelial Cl− secretion by inhi-
biting the endocytic recycling of CFTR in polarized human
airway epithelial cells [30]. Our results raise the possibility that
physiologic and pathologic factors that influence WASP activity
may modify CFTR expression or functional activity at the
plasma membrane. Future studies will be aimed at identifying
such factors and determining their role in regulating CFTR
surface expression and activity.
4.1. CFTR surface expression and activity are reduced by
wiskostatin and latrunculin B
We observed a dose-dependent decrease in CFTR surface
expression following wiskostatin treatment of BHK-CFTR cellsin biotinylation studies. A large fraction of CFTR (∼80%) was
lost from the cell surface at 100 μM wiskostatin. There was no
change in the total CFTR content in the lysates at all doses of
wiskostatin indicating that there was no apparent degradation of
CFTR under these conditions. The steady-state surface CFTR
expression presumably reflects a balance between rates of
internalization and of recycling back to the cell surface. Our
results indicate that both wiskostatin and latrunculin B shifted
the steady-state distribution towards greater amounts of CFTR
inside cells while depleting the ion channel from the cell surface
(Fig. 2). Similar results were also obtained with cytochalasin D,
a standard actin-disrupting reagent that binds to the growing
ends of the actin filaments (unpublished observations). How-
ever, the effect of wiskostatin was most consistent and
reproducible in these experiments.
The biochemical results were corroborated by functional
studies performed in cultured cells. CFTR-mediated Cl−
currents were strongly inhibited by wiskostatin and latrunculin
B both in BHK fibroblast cells that express high levels of
recombinant CFTR and in HT29-CL19A epithelial cells that
express low levels of native CFTR. The correlation between the
results of the biochemical and functional studies favors the idea
that these reagents greatly reduce the number of CFTR channels
expressed at the cell surface. However, we observed that the
dose of wiskostatin required to inhibit CFTR-mediated currents
by >80% in membrane patches excised from BHK-CFTR cells
(5 μM; Fig. 2) was less than the dose which resulted in 80%
reduction in surface CFTR expression biochemically (100 μM;
Fig. 1). One possible explanation is that the readouts for the
surface biotinylation assay and the functional (patch clamp)
assay cannot be directly compared, because the assays are
performed under different conditions (intact cells versus broken
cell assays) that may differently affect the actin cytoskeleton.
However, we cannot rule out that the reagent could affect the
regulation of individual CFTR channels as well. It seems
unlikely that wiskostatin directly inhibits CFTR channels given
that (i) wiskostatin binds to its specific target (N-WASP) in vitro
with an apparent Kd of ∼100 μM [17] and (ii) adding
wiskostatin directly to the cytoplasmic side of excised
membrane patches did not result in an acute reduction of
CFTR-mediated currents. This, however, does not rule out other
possibilities that have been proposed in the literature such as (i)
CFTR activity is modulated by a direct interaction with actin
filaments [31] or (ii) wiskostatin indirectly affects CFTR gating
within intact cells by releasing a cellular kinase or phosphatase
inhibitor that is tethered to F-actin filaments [32].
4.2. Cyclic-AMP inhibits CFTR internalization in the presence
or absence of wiskostatin
There is a growing notion that phosphorylation of the CFTR
channel and/or its functional activity can modulate its surface
expression in some cell types. Prince et al., demonstrated that
stimulation with cyclic-AMP decreased the internalization of
CFTR from the cell surface by ∼60% in T-84 epithelial cells
[1]. Lukacs et al., similarly reported that activation of PKA
inhibited the rate of CFTR endocytosis in stably transfected
199R. Ganeshan et al. / Biochimica et Biophysica Acta 1773 (2007) 192–200Chinese hamster ovary cells [2]. Other investigators postulated
that cyclic-AMP also stimulated exocytosis/recycling of CFTR
to the cell surface [7]. Thus, cyclic-AMP could affect CFTR
expression at the cell surface by (i) inhibiting endocytosis or (ii)
enhancing recycling. In the present study we observed that
cyclic-AMP inhibited CFTR internalization both in the presence
and absence of wiskostatin, although this effect was partially
attenuated by wiskostatin (Fig. 5). The results indicate that (i)
wiskostatin and cyclic-AMP have opposite effects on CFTR
expression at the cell surface and (ii) cyclic-AMP can partially
override the effects of wiskostatin on CFTR internalization (or
recycling; see below). It seems plausible that wiskostatin and
cyclic-AMP primarily affect different steps in CFTR trafficking;
on the one hand CFTR is endocytosed more slowly from the cell
surface (as an effect of cyclic-AMP), whereas wiskostatin
inhibits recycling of the internalized CFTR (see below). This
could possibly explain the greater accumulation of CFTR inside
cells in the presence of both cyclic-AMP and wiskostatin.
4.3. Models to explain effects of wiskostatin on CFTR surface
expression
The results of this study support the existence of regulated
CFTR trafficking which requires an appropriate balance
between (i) internalization of CFTR into endocytic vesicles
(endocytosis) and (ii) redistribution of internalized channels
back to the plasma membrane (endocytic recycling). Wiskos-
tatin and latrunculin B could affect the distribution of CFTR
between these two compartments by (a) enhancing endocytosis
from the cell surface, thereby increasing the intracellular pool of
CFTR or (b) inhibiting recycling of endocytosed CFTR back to
the cell surface (Fig. 7). These possibilities are not mutually
exclusive. An effect of wiskostatin on endocytosis is supported
by the kinetic data (Fig. 6) which indicated that wiskostatin
increased the fraction of surface-labeled CFTR that was
endocytosed at early time points. It is possible that some
CFTR at the cell surface is tethered to the actin cytoskeleton
either directly [31] or indirectly via PDZ-domain interactionsFig. 7. Model(s) to explain wiskostatin effects on CFTR trafficking. Wiskostatin
could affect the distribution of CFTR between the cell surface and intracellular
compartments by (A) enhancing endocytic retrieval of CFTR from the plasma
membrane, (B) inhibiting the recycling of endocytosed CFTR back to the cell
surface or (C) translocating CFTR to an off-pathway intracellular compartment.with proteins that bind actin (e.g., NHERF1/EBP50, NHERF2/
E3KARP and ezrin) [33–35]. Wiskostatin could increase the
endocytic retrieval of CFTR by disrupting such interactions
thereby increasing the proportion of surface CFTR that can be
endocytosed. In support of this model, actin disruption by
latrunculin A was proposed to release AMPA receptors from
their anchoring to the post-synaptic membrane, thus allowing
them to enter the perisynaptic endocytic pathway [36]. Such a
putative mechanism would also be consistent with the
observation that cyclic-AMP is able to inhibit CFTR inter-
nalization even in the presence of wiskostatin; depolymerization
of actin by wiskostatin may untether CFTR from the cell
surface, whereas cyclic-AMP may inhibit a downstream step in
the endocytic pathway. Alternatively, wiskostatin could
enhance the kinetics of internalization for an untethered
population of CFTR, although this model would not be
consistent with the reported positive role of N-WASP in
regulating the endocytosis of other proteins [20]. Regarding a
possible effect of wiskostatin on recycling, it is interesting to
note that the endocytic accumulation of CFTR reached steady-
state rapidly (within 2 min) under control conditions, suggesting
that the internalized CFTR was efficiently recycled back to the
cell surface under these conditions. In contrast, there was slow
accumulation of CFTR in the wiskostatin-treated cells that
reached steady-state very gradually (Fig. 6). Thus, whether we
assume all CFTR at the plasma membrane to be freely endo-
cytosed or exist as two populations (tethered and untethered),
one would have observed a rapid increase in the CFTR signal
only in the initial few minutes if wiskostatin augmented the
endocytic retrieval of CFTR alone. Therefore, the slower
accumulation of CFTR in the wiskostatin-treated cells suggests
that the recycling pathway had to be inhibited or saturated,
which resulted in a net increase in the intracellular pool of
CFTR. It is therefore likely that wiskostatin also compromises
the recycling efficiency of CFTR. A more definitive conclusion
would be possible if we could directly measure the recycling
kinetics of CFTR in control and wiskostatin-treated cells.
However, the rapid kinetics of CFTR endocytosis, especially in
the wiskostatin-treated cells (Fig. 6), precluded accurate
measurements of the initial (unidirectional) rates of CFTR
recycling in BHK cells (unpublished observations).
It is noteworthy that CFTR remained undegraded over a
period of 2 h in the wiskostatin-treated cells, which suggests
that the protein was possibly trapped in the recycling compart-
ment (or an off-pathway compartment). Picciano et al., have
reported that CFTR is trapped in an intracellular compartment
when a regulator of membrane recycling (Rme-1) is inhibited
[6]. Conceivably, wiskostatin could have similar effects. Pre-
liminary results indicate that there is partial recovery of surface
CFTR levels when cells are transferred to regular medium
following wiskostatin treatment (data not shown), suggesting
that CFTR is not permanently trapped within the cells.
In conclusion, the results reported in this paper implicate
a role of N-WASP and actin in regulating CFTR expression
and activity at the cell surface. Wiskostatin, an allosteric
inhibitor of N-WASP activity, has potent and complex
effects on CFTR endocytosis and recycling. The net effect
200 R. Ganeshan et al. / Biochimica et Biophysica Acta 1773 (2007) 192–200was a marked redistribution of CFTR from the cell surface into
intracellular compartments without CFTR degradation. Physio-
logic or pathologic factors (e.g., Rho-GTPase inhibitors,
bacterial toxins, etc) that modulate N-WASP activity and
influence actin assembly could influence CFTR surface ex-
pression by this mechanism.
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